رجوع
نطاق اليوم
KWD 40.50
KWD 42.02
نطاق 52 أسبوعًا
KWD 30.08
KWD 62.18
حجم التداول
384,872
متوسط 50 يوم / 200 يوم
KWD 41.39
/
KWD 47.11
الإغلاق السابق
KWD 42.11
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -6.1 | 0.3 |
| P/B | 8.5 | 2.9 |
| ROE % | -132.9 | 3.7 |
| Net Margin % | -89.9 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 56.880
+39.0%
Low: KWD 50.000
High: KWD 68.000
مكرر الربحية المستقبلي
21.7
ربحية السهم المستقبلية
KWD 1.940
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
740 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 3.790
KWD 3.684 – KWD 3.925
|
1.4 B | 1 |
| FY2029 |
KWD 3.380
KWD 3.285 – KWD 3.501
|
1.2 B | 1 |
| FY2028 |
KWD 3.013
KWD 2.811 – KWD 3.215
|
1 B | 2 |
النقاط الرئيسية
Debt/Equity of 0.02 — conservative balance sheet
Generating 170.73M in free cash flow
Capital efficient — spends only 0.12% of revenue on capex
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)50.58%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-132.86%
ROIC-106.00%
Net Margin-89.86%
Op. Margin-92.94%
الأمان
Debt / Equity
0.02
Current Ratio1.47
Interest Coverage0.00
التقييم
P/E Ratio
-6.10
P/B Ratio8.51
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 50.58% | Revenue Growth (3Y) | 41.71% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 587.86M | Net Income (TTM) | -528.26M |
| ROE | -132.86% | ROA | -70.93% |
| Gross Margin | 79.65% | Operating Margin | -92.94% |
| Net Margin | -89.86% | Free Cash Flow (TTM) | 170.73M |
| ROIC | -106.00% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.02 | Current Ratio | 1.47 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -6.10 | P/B Ratio | 8.51 |
| P/S Ratio | 5.48 | PEG Ratio | 0.00 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 3.22B | Enterprise Value | 3.02B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 587.86M | 390.40M | 292.73M |
| Net Income | -528.26M | -11.93M | -108.14M |
| EPS (Diluted) | -5.19 | -0.15 | -1.39 |
| Gross Profit | 468.22M | 300.59M | 194.18M |
| Operating Income | -546.37M | -24.43M | -130.51M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | 744.76M | 673.26M | 622.53M |
| Total Liabilities | 366.23M | 256.56M | 195.25M |
| Shareholders' Equity | 378.54M | 416.70M | 427.28M |
| Total Debt | 8.04M | 11.07M | 15.73M |
| Cash & Equivalents | 208.00M | 300.79M | 234.95M |
| Current Assets | 533.90M | 583.45M | 529.88M |
| Current Liabilities | 362.41M | 249.30M | 184.16M |